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INTRODUCTION
Multimorbidity is common, even in younger 
ages than previously imagined, and 
especially for low-income groups.1–3 There 
is a growing international agreement for 
solutions to multimorbidity to exist in primary 
care settings and to be patient centred.4,5 
However, patient-centred interventions 
for people with multimorbidity vary 
greatly, typically including both principles 
of partnership between the patient and 
health professional6,7 and aspects of system 
integration,8 as well as some technologies.9 
Evidence of effectiveness is inconsistent,8,10–12 
including that gleaned from six recent 
trials.13-18 It is becoming clear that work must 
be continued to improve the interventions;19 
testing them and illuminating mechanisms 
of success and failure may assist with the 
making of such improvements19 so this study 
had two research goals:
• to assess the effectiveness of a flexible 
patient-centred innovation (which arose 
from real-world practice in the policy 
context of Ontario, Canada) in relation to 
relevant patient-reported outcomes; and 
• to ascertain the contexts, and under what 
circumstances, the innovation worked or 
did not work for patients. 
A concurrent triangulation mixed-
methods study20 was mounted with two 
simultaneous components: a pragmatic21,22 
trial for first aim and a qualitative study of 
patients’ experience for the second.
METHOD
Trial
Participant eligibility. Patients were eligible 
for the trial if they:
• were literate; 
• were aged 18–80 years old; 
• had never before received the intervention; 
and
• in the family physician’s (FP’s) clinical 
judgement, were cognitively intact and 
had ≥3 chronic conditions.23,24
Abstract
Background
Patient-centred interventions to help patients with 
multimorbidity have had mixed results.
Aim
To assess the effectiveness of a provider-created, 
patient-centred, multi-provider case conference 
with follow-up, and understand under what 
circumstances it worked, and did not work.
Design and setting
Mixed-methods design with a pragmatic 
randomised trial and qualitative study, involving 
nine urban primary care sites in Ontario, Canada. 
Method
Patients aged 18–80 years with ≥3 chronic 
conditions were referred to the Telemedicine 
IMPACT Plus intervention; a nurse and patient 
planned a multi-provider case conference during 
which a care plan could be created. The patients 
were randomised into an intervention or control 
group. Two subgroup analyses and a fidelity 
assessment were conducted, with the primary 
outcomes at 4 months being self-management 
and self-efficacy. Secondary outcomes were 
mental and physical health status, quality of 
life, and health behaviours. A thematic analysis 
explored the patients' experiences of the 
intervention.
Results
A total of 86 patients in the intervention group and 
77 in the control group showed no differences, 
except that the intervention improved mental 
health status in the subgroup with an annual 
income of ≥C$50 000 (β-coefficient 11.003, 
P = 0.006). More providers and follow-up hours 
were associated with poorer outcomes. Five 
themes were identified in the qualitative study: 
valuing the team, patients feeling supported, 
receiving a follow-up plan, being offered new and 
helpful additions to their treatment regimen, and 
experiencing positive outcomes. 
Conclusion
Overall, the intervention showed improvements 
only for patients who had an annual income 
of ≥C$50 000, implying a need to address the 
costs of intervention components not covered by 
existing health policies. Findings suggest a need 
to optimise team composition by revising the 
number and type of providers according to patient 
preferences and to enhance the hours of nurse 
follow-up to better support the patient in carrying 
out the case conference’s recommendations.
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The upper age limit of 80 years was 
chosen to minimise loss to follow-up 
because the participant had been admitted 
to an institution. The threshold of ≥3 chronic 
conditions was chosen for two reasons:
• this is likely to engender more burden 
for the patient and the FP than the other 
common definition of multimorbidity of ≥2 
conditions; and 
• as the patients had more medical needs, 
the researchers felt they had the potential 
for a greater level of improvement in 
outcomes.
The number of chronic conditions was 
validated with the patient’s self-report in the 
baseline questionnaire.
Design and setting. A pragmatic randomised 
trial was conducted with nine team-based 
family practices that were familiar with the 
intervention (along with solo practices and 
emergency departments affiliated with 
those teams) in Toronto, Ontario, Canada. 
The provincial policy context emphasised 
innovations for complex patients with high 
healthcare utilisation.25
Ethics approval was received and the 
protocol has been published.26 The trial was 
registered in Ontario, Canada (NCTO2742597), 
and the CONSORT guidelines for pragmatic 
trials were followed for reporting methods 
and results.27
Intervention development. A patient-centred, 
multi-provider case conference — the 
Telemedicine IMPACT Plus (TIP) programme 
— was developed by the providers, then 
chosen by the researchers from six 
programmes identified in a province-wide 
environmental scan. The intervention was 
chosen because of its lengthy development 
and preliminary evaluation. It was developed 
in a way that aligned with guidelines for 
complex interventions,28–30 covering theory, 
gaps, pre-trial evaluations, and adaptation 
over time, and contained two key theoretical 
underpinnings — namely a patient-centred 
process6 in the patient–provider interaction 
and an integrated version of the Chronic 
Care Model.31
Two evidence gaps from a scoping review32 
that had been conducted by the team 
were lack of empowering patient-centred 
communication and lack of integrated care 
among multiple providers in the context of 
multimorbidity care. Pre-trial evaluations of 
early versions, which had a longer face-to-
face component but less follow-up support, 
of the intervention revealed enablers of and 
barriers to patient and provider enthusiasm 
relating to:
• time and scheduling of the multiple 
providers;33
• patient need for support to implement 
recommendations;33
• patient-centred agenda setting;34
• the process of identifying and inviting 
patients;34 and 
• remuneration of providers.34
Over a period of 10 years, the intervention 
was shortened, provided a telemedicine 
(video) option in addition to the face-to-face 
option, and remuneration was negotiated. 
The patient-centred invitation to patients 
to engage in the discussion, which was not 
explicit before, was made explicit and was 
honed: ‘What are your goals for this session?’ 
was asked in the context of improved agenda 
setting. 
The TIP programme. A nurse, hired by the 
programme, met with each patient face to 
face for approximately 1 hour to understand 
what mattered to them, and then planned 
and coordinated a case conference of 
approximately six providers relevant to that 
patient from the following:
• FP (known to the patient); 
• internist; 
• psychiatrist; 
• social worker; 
• physiotherapist; 
• occupational therapist; 
How this fits in 
Patient-centred interventions for patients 
with multimorbidity have shown mixed 
results to date, so there is a need to help 
improve them. The present study indicated 
that the intervention implemented had 
a neutral impact on primary outcomes. 
Given the subgroup results in which the 
intervention showed improvements only 
for patients with an annual income of 
≥C$50 000, the qualitative findings, and 
the fidelity assessment, policymakers 
and clinicians are encouraged to seek 
ways to enhance care for patients with 
annual incomes of <C$50 000, to optimise 
team composition based on an individual 
patient’s preferences and abilities, and 
to enhance and tailor follow-up care by 
ensuring the creation of a coherent plan 
with actionable steps. 
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• pharmacist; 
• dietitian; and 
• home care case manager.
In preparation for the case conference, 
the nurse accessed the patient’s file from 
the FP and forwarded all relevant medical 
and social history to the intervention team. 
The providers met (face to face or by video) 
with the patient for 1–1.5 hours so all parties 
could, through mutual collaboration, focus 
on the patient’s goals and develop an agreed 
care plan. Follow-up was provided by the 
nurse to help execute the recommendations 
over the subsequent 4 months. A full 
description is shown in Supplementary Box 
S1 using the TIDieR Checklist.35
TIP and the literature. The literature 
describes three main intervention types: 
patient-oriented, organisational, and training 
interventions.8.36 Combining 47 trials from 
two reviews,8,36 the researchers found that 
patient-oriented interventions were tested 
in 36% of trials, organisational interventions 
were tested in 51% of trials (of which all 
also had a patient-oriented component), and 
training interventions were tested in 13% of 
trials; training was not an element of the 
intervention presented here. The focus on 
patient goals was a common thread in all 
the patient-oriented interventions; however, 
TIP’s multi-provider team was unique and 
not found in any of the 47 interventions — 
the closest thing being a team comprising 
the practice nurse, a psychologist, and a 
psychiatrist.37
Pilot evaluation of the TIP programme. A 
pragmatic randomised pilot study to 
determine the feasibility of suggested 
outcomes, to estimate recruitment, and 
to identify effect sizes for sample size 
calculation was conducted.38
Description of usual care. Patients in the 
control group received usual care in the 
office of their FP (typically a 15-minute visit) 
and a one-page list of community resources 
that patients with their conditions could 
contact if desired. The three-quarters of 
patients were referred by FPs who worked 
in an interprofessional team on site and 
a quarter were not. The three-quarters 
worked in Ontario’s model of team-based 
care, called the Family Health Team (FHT), 
which meant that a nurse practitioner and 
social worker would be readily available on 
site; the patients comprising a quarter of the 
control group were referred by FPs who were 
in a non-team practice but who could refer 
patients to medical specialists and health 
professionals off site. 
Recruitment. Nine team-based practices 
and their affiliated practitioners referred 
eligible patients. There was a two-step 
recruitment process. Patient selection was 
based on clinical judgement and clinicians 
approached patients and requested consent 
to send their name to the researchers. The 
project coordinator received names and 
contact details of patients, and contacted 
them by telephone to explain the project 
in detail and obtain signed consent to 
participate.
Outcomes. Outcomes were assessed at 
baseline and at 4 months after the case 
conference, a period considered long enough 
for the nurse and patient to complete the plan 
and feasible for follow-up to the trial. Two 
primary outcome measures were chosen to 
represent patient education, empowerment, 
and agency:
• the Health Education Impact Questionnaire 
(heiQ);39 and 
• the Self-Efficacy for Managing Chronic 
Disease scale (SEM).40 
There were four secondary outcome 
measures: 
• VR12 Health Status — Physical Component 
Score and Mental Component Score;41
• EQ-5D quality of life;42
• Kessler Psychological Distress Scale;43 
and 
• Health Behaviour Survey.44 
Psychometric properties are available in 
the protocol article for the project.26
Sample size. For the two primary outcome 
measures (heiQ and SEM), comparing mean 
scores to detect a medium effect size (0.5) 
with a two-sided α = 0.05 and 80% power 
resulted in 64 participants being needed 
in both the intervention group and the 
control group; this equated to a sample size 
of = 128.45 Allowing for a 15% drop-out, the 
researchers aimed to recruit 150 patients, 
with 75 in each group. 
Randomisation. Individual patients were 
allocated using randomly sequenced 
envelopes. Supplementary Box S2 details 
the procedures using the CONSORT 
guidelines27 regarding assignment of the 
intervention, sequence generation, allocation 
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concealment, implementation, blinding, and 
data collection. 
Statistical methods. Outcome data were 
analysed using the mixed model for 
repeated measures (MMRM).46 This method 
is a simple form of mixed effect; it does 
not explicitly model the random effects 
but, rather, explicitly models correlations 
among measurements within a subject. An 
advantage is that it can effectively handle 
missing data without strong assumptions 
that missing data occurred randomly. It 
also controlled for the baseline outcome 
measure. Nonetheless, a sensitivity analysis, 
omitting the lost cases, was conducted. 
Two exploratory, post-hoc, subgroup 
analyses were conducted, on:
• <$50K annual income versus ≥$50K 
annual income (the sample’s median 
income); and 
• ≥6 morbidities versus fewer (again, using 
MMRM).
In addition, the relationship between the 
fidelity of the intervention (involving a subset 
of 40 patients from the intervention group) 
and outcomes was analysed using analysis 
of covariance, controlling for baseline.
Qualitative study 
Design. A thematic analysis47 was used to 
explore the patients’ experiences of context, 
process, and under what circumstances the 
intervention worked or failed to work. It was 
undertaken at the same time as the trial 
measures were being collected. 
Participant recruitment and final 
sample. Participants were selected 
purposively from those in the trial intervention 
arm. A maximum-variation sample varied by 
age, sex, and practice. 
Data collection. Participants were 
interviewed 4 months after their TIP case 
conference at a time and date organised by 
the study research coordinator. Interviewers 
had no prior relationship with participants. 
Before the interview, participants read the 
letter of information that outlined the reasons 
for the qualitative study and informed 
consent for the interview was obtained. 
Semi-structured individual interviews 
(Supplementary Box S3) were conducted 
with each participant alone in their home or 
the FP’s office. These lasted 30–60 minutes, 
and were audio-recorded and transcribed 
verbatim. Four members of the research 
team trained in conducting qualitative 
interviews undertook the collection and 
analysis of the qualitative data; they were 
not involved in the collection of the trial data.
Data analysis. The data analysis was both 
iterative and interpretive. All transcripts 
were independently reviewed and coded by 
the four researchers to determine the key 
emerging concepts. They then met, shared, 
and created a consensus that informed the 
development of the coding template. This 
process continued until no new themes were 
identified; the data were input into NVivo 
10. In the final step, the research team 
identified overarching themes and exemplar 
quotations for each theme. 
Trustworthiness and credibility were 
ensured using audio-recordings, verbatim 
transcripts, independent as well as team 
analysis, and field notes following each 
interview. A commitment to reflexivity 
considered how the researchers’ professional 
backgrounds (for example, social work, 
epidemiology, family medicine), particularly 
during the coding and interpretation of the 
data, could influence the findings.
RESULTS
Trial
Participants. Figure 1 shows the flow 
diagram of the patient recruitment process. 
The sample attained was 86 for the 
intervention group and 77 for the control 
group. This sample differed from the general 
Ontario population48 in that it was older, 
comprised more females and participants 
had a higher level of education and a higher 
income. 
Baseline patient characteristics are 
shown in Table 1. As expected, due to 
randomisation there were no statistically 
significant differences. 
Outcomes and estimates. Table 2 shows 
the intent-to-treat analyses of primary 
outcomes in the intervention and control 
groups at 4 months; no statistically significant 
differences are in evidence. Tables 3 and 
4 shows similar lack of difference on the 
secondary outcomes. Tables 2–4 show for 
the most part modest improvements from 
baseline to 4-month follow-up in both groups.
Ancillary analyses. Subgroup analyses 
showed no difference in the effect of the 
intervention for patients with ≥6 chronic 
conditions versus <6 (data not shown); 
however, as shown in Figure 2, the 
intervention effect differed significantly in 
the two income groups. The intervention 
group’s mental health status increased in 
the ≥C$50 000 patients and the usual-care 
control group’s increased in the <C$50 000 
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patients (β-coefficient 11.003, P = 0.006). 
Exploratory analyses regarding the fidelity 
of the interaction revealed two components 
that could be altered to improve the 
intervention, as follows (data not shown):
• having ≥3 hours (versus fewer hours) of 
nurse follow-up work within 4 months 
of the case conference was related to 
statistically significantly less improvement 
in primary outcomes from baseline to 
4-month follow-up; and 
• having ≥6 healthcare providers involved in 
the intervention (versus <6 providers) was 
related to less improvement.
Qualitative study
The final sample comprised 14 patients (six 
men, eight women), aged 33–80 years. Five 
themes reflected the patients’ experience of 
the intervention:
• valuing the team experience; 
• feeling supported in meeting their goals; 
• receiving advice and a follow-up plan; 
• being offered new and helpful additions to 
their treatment regimen; and 
• experiencing positive outcomes.
Valuing the team experience. This theme 
included all players sharing the same 
information and having buy-in to the 
recommended plans, which participants felt 
was valuable:
‘The nurse got together a dietitian, my family 
doctor, a social worker, a psychiatrist, a 
pharmacist — a whole bunch of people 
together … We had a video here [at my 
home], a conversation and just so everybody 
was on the same page with what I was doing. 
It was really good.’ (Participant 4, female)
In addition, the diversity of team members 
meant connections to a lot of programmes 
could be made, which was found to be 
helpful: 
‘Because I have various health issues, this 
gave me some kind of all-in-one resource!!’ 
(Participant 11, male) 
However, a down side was that the new 
services could be exhausting:
‘I had so many appointments after [the 
consultation], it was tiring!!’ (Participant 4, 
female)
Feeling supported in meeting goals. The 
multi-provider case conference made 
patients feel that they were supported in 
terms of meeting their goals:
‘I felt that they truly were committed to the 
interview and looking to see if they could help 
me to reach my goals … It was often they’d 
have a perspective and then I’d respond to 
that as well. Or they’d ask me how I felt about 
that.’ (Participant 8, female)
In addition, their goals were explicitly 
elicited:
‘I was asked, “What do you want from this?” 
So I said, “I would like to be able to walk a 
mile … I am not asking to run a marathon, 
just a mile without pain”.’ (Participant 7, male) 
Patients felt validated during the case 
conference: 
‘Well they heard me … they validated me. So 
that wasn’t happening [before].’ (Participant 
4, female)
Receiving advice and a follow-up plan. The 
advice given was considered plentiful, new, 
and helpful:
Figure 1. Flow chart of patients.
Analysed control (n = 77) 
Assessed at follow-up 4 months
post-baseline (follow-up; n = 67)
• Withdrew before follow-up (n = 3)
• Lost to follow-up before
   follow-up (n = 7)
Analysed intervention (n = 86) 
Allocated to control baseline
(n = 77)
• Received resources (n = 75)
• Did not receive resources (n = 2)
Allocated to intervention baseline (n = 86)
• Received intervention (n = 76)
• Did not receive intervention (n = 10)
      ° Withdrew before intervention (n = 8)
      ° Intervention date set outside of study
         period (n = 2)
Allocation
Total excluded (n = 123)
• Did not meet inclusion criteria (n = 13)
• Declined to participate (n = 50)
• Unable to contact (n = 47)
• Reason unknown (n = 3)
• Clinician judged that patient required
   the intervention (n = 10)
Screening assessed
for eligibility (n = 288)
Enrolment (n = 165)
Withdrew before randomisation (n = 2)
Randomised
Assessed at follow-up 4 months post-
intervention (follow-up; n = 73)
• Lost to follow-up before follow-up (n = 3)
• The n = 13 not followed up were:
       ° 58.3 years old on average
       ° 23.1% male
       ° 38.5% income of $50K CAD or more
Analysis
Follow-up
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‘I felt really good coming out of that. That 
was some of the best answers [sic] I felt like 
I’d received up to that point … I came out 
of it with kind of a list of ideas of different 
things to try to help improve my condition.’ 
(Participant 1, male)
In some instances, patients felt it was the 
best part of the programme.
Patients appreciated receiving a 
summary of the recommendations from the 
consultation: 
‘The nurse came back [to the patient’s 
home] a week after that with a synopsis 
of everything that was written down and 
reviewed everything, not word for word, but 
the highlights, a summary of everything.’ 
(Participant 7, male)
A few patients noted that, when presented 
with only verbal instructions or a list that 
was not coalesced into a plan, they were left 
with little guidance at the conclusion of the 
consultation: 
‘It has been frustrating not to have a little 
bit more guidance about how to take the 
individual suggestions and put those into an 
actual plan … The list I was given seemed 
to be in the order they thought of them and 
not really further processed into an actual 
treatment plan with step-by-step priorities.’ 
(Participant 12, female)
Being offered new and helpful additions to 
their treatment regimen. Patients described 
how receiving new solutions to their health 
issues enhanced their treatments in spite of 
some treatments not being covered by the 
provincial healthcare plan:
‘Clear solutions yeah … a walker … 
medication … eating … that pleases me very 
much …’ (Participant 12, female) 
‘As a result of this intervention, the social 
worker arranged for me to get a walker. 
So I go out for walks now, which I hadn’t 
been doing for the longest time. I find it very 
liberating.’ (Participant 5, male)
Psychotherapy and physiotherapy were 
repeatedly mentioned as helpful additions to 
patients’ treatment regimens:
‘The psychotherapist is a good match for 
me and positive work is being done. I am 
over the moon, optimistic.’ (Participant 13, 
female)
‘I feel like the physiotherapist has been 
helping. Yeah, anything that gets your strength 
back is wonderful … Especially muscles, 
because you can get them back, and I didn’t 
know how to do it.’ (Participant 12, female)
Experiencing positive outcomes. Participants 
described their health improvements, 
attributed to the programme, which reflected 
two dimensions — namely, improved 
Table 1. Patient baseline characteristics of the intervention (n = 86) 
and control (n = 77) groups
 Intervention Control P-value  
Age in years, mean (SD) 61.9 (13.9) 63.1 (13.9) 0.941 
Chronic conditions,a   
 No. conditions per participant, mean (SD)  6.1 (2.5)  5.9 (2.3)  0.414 
Type of condition, n (%)
 Arthritis or rheumatoid arthritis 51 (59.3) 45 (58.4) 0.936
 Depression or anxiety 49 (57.0) 40 (51.9) 0.497
 Hypertension 47 (54.7) 40 (51.9) 0.253
 Chronic musculoskeletal 46 (53.5) 29 (37.7) 0.027
 Stomach problems 42 (48.8) 36 (46.8) 0.518
 Colon problems 35 (40.7) 24 (31.2) 0.167
 Hyperlipidaemia 33 (38.4) 29 (37.7) 0.412
 Asthma or COPD 32 (37.2) 29 (37.7) 0.644
 Cardiovascular disease 31 (36.0) 35 (45.5) 0.595
 Diabetes 30 (34.9) 28 (36.4) 0.861
 Thyroid disorder 22 (25.6) 17 (22.1) 0.566
 Osteoporosis 20 (23.3) 20 (26.0) 0.773
 Chronic urinary problem 13 (15.1) 13 (16.9) 0.955
 Stroke or TIA 13 (15.1) 9 (11.7) 0.390
 Heart failure (valve problem 12 (14.0) 12 (15.6) 0.913 
 or replacement)
 Cancer in previous 5 years 10 (11.6) 12 (15.6) 0.668
 Kidney disease or failure 9 (10.5) 7 (9.1) 0.616
Male,  n (%) 29 (33.7)  27 (35.1) 0.632 
Education level , n (%)   
 Incomplete secondary school 10 (11.6) 8 (10.4) 
 Completed secondary school 9 (19.5) 11 (14.3) 
 Some university or 26 (30.2) 27 (35.1) 0.755 
 completed college
 University (undergraduate or 40 (46.5) 31 (40.3)  
 above completed)
Household income , n (%)    
 <C$20 000 20 (23.3) 17 (22.1) 
 C$20 000–49 999 13 (15.1) 22 (28.6) 0.203
 ≥C$50 000  42 (48.8) 29 (37.7) 
 Missing data 11 (12.8) 9 (11.7) 
Marital status , n (%)   
 Married 37 (43.0) 37 (48.1) 
 Separated or divorced 17 (19.8) 15 (19.5) 0.494
 Widower 8 (9.3) 11 (14.3) 
 Never married 23 (26.7) 14 (18.2) 
Employment , n (%)    
 Employed 17 (19.8) 14 (18.2) 
 Unemployed 31 (36.0) 28 (36.4) 0.967
 Retired 37 (43.0) 34 (44.2) 
aHIV and chronic hepatitis not included as cell counts were < 5, in spite of their inclusion in the list of chronic 
conditions.22 COPD = chronic obstructive pulmonary disease. SD = standard deviation. TIA = transient ischaemic 
attack.
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functional ability and a new positive, hopeful 
attitude:
‘So I have had some improvement in 
being able to do things around the house.’ 
(Participant 12, female)
For some patients, increased function was 
due to a decrease in pain: 
‘I’m feeling better. I don’t have the horrible 
pain that I had before … I feel that I have the 
ability to do things now that a few months 
ago I wouldn’t think of doing.’ (Participant 
5, male)
Table 2. Intention-to-treat analyses of primary outcomes at 4-month follow-up in the Telemedicine 
IMPACT Plus study
 Interventiona Control
 Baseline Follow-up Baseline Follow-up β-coefficient (95% CI)b P-value
Participants, n 86 73 77 67  
heiQ outcomes,c mean (SD)      
 Health-directed behaviour 2.72 (0.748) 2.86 (0.586) 2.83 (0.725) 2.93 (0.579) 0.049 (–0.149 to 0.247) 0.626
 Positive, active, engaged life 2.90 (0.617) 2.93 (0.531) 2.84 (0.587) 2.95 (0.506) –0.067 (–0.231 to 0.098) 0.429
 Emotional wellbeing 2.42 (0.744) 2.56 (0.581) 2.45 (0.712) 2.61 (0.592) –0.018 (–0.189 to 0.153) 0.836
 Self-monitoring and insight 3.07 (0.372) 3.10 (0.277) 3.13 (0.355) 3.14 (0.305) 0.024 (–0.090 to 0.138) 0.681
 Constructive attitudes and approaches 2.90 (0.644) 2.88 (0.464) 2.87 (0.572) 2.96 (0.526) –0.108 (–0.264 to 0.048) 0.174
 Skill and technique acquisition 2.75 (0.512) 2.83 (0.366) 2.76 (0.430) 2.94 (0.420) –0.082 (–0.219 to 0.055) 0.243
 Social integration and support 2.80 (0.679) 2.85 (0.499) 2.68 (0.647) 2.87 (0.524) –0.152 (–0.309 to 0.005) 0.057
 Health services navigation 3.13 (0.482) 3.11 (0.408) 3.11 (0.475) 3.17 (0.455) –0.064 (–0.207 to 0.079) 0.381
Self-Efficacy for Managing Chronic Disease scale scored  5.69 (2.269) 5.93 (2.057) 5.59 (2.199) 6.06 (2.114) –0.184 (–0.831 to 0.463) 0.577
aA sensitivity analysis, omitting the 10 patients who did not receive the intervention, was conducted and obtained similar results. bAnalysis by mixed-model repeated measures using 
Stata, version 13. cRange: 1 (low)–4 (high). dRange: 1 (low)–10 (high). CI = confidence interval. heiQ = Health Education Impact Questionnaire. SD = standard deviation.
Table 3. Analysis of secondary continuous outcomesa at 4-month follow-up
 Intervention Control
 Baseline Follow-up Baseline Follow-up β-coefficient (95% CI)a P-value
Participants, n 86 73 77 67  
Health status, mean (SD)b
 Physical 34.09 (11.851) 36.61 (10.670) 34.16 (10.474) 37.05 (11.995) 0.274 (–2.775 to 3.323) 0.860
 Mental  42.66 (13.592) 43.86 (13.506) 44.01 (13.783) 46.23 (13.119) –1.402 (–5.055 to 2.251) 0.452
Quality of life 0.66 (0.247) 0.66 (0.257) 0.67 (0.246) 0.64 (0.237) 0.037 (–0.034 to 0.109) 0.307
aAnalysis by mixed-model repeated measures, using Stata (version 13). bRange: 1 (low) to ≥66 (high). CI = confidence interval.
Table 4. Analysis of secondary dichotomous outcomesa at 4-month follow-up
 Intervention Control
 Baseline Follow-up Baseline Follow-up Odds ratio (95% CI)a P-value
Participants, n 86 73 77 67
Psychological distress, % 18.60 15.49 19.48 13.64 1.490 (0.241 to 9.197) 0.668
Health behavioursb
 No alcohol 42.86 39.73 42.86 38.81 1.161 (0.143 to 9.453) 0.889
 Physical activity ≥2 times per week 41.86 57.53 53.25 59.70 2.197 (0.595 to 8.110) 0.237
 Good–excellent healthy eating 52.94 63.01 61.04 67.16 1.792 (0.362 to 8.882) 0.475
 Healthy BMIc 62.65 56.94 60.81 56.92 0.475 (0.066 to 3.432) 0.461
aMulti-level mixed-effects logistic regression using Stata (version 13). bYes = healthy behaviour. c<30. BMI = body mass index. CI = confidence interval.
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Improved functional ability appeared 
linked to a sense of hope: 
‘There are things that I’m looking forward 
to, which before the intervention I wasn’t.’ 
(Participant 5, male) 
‘Without it, I would be sitting here miserable … 




The trial found the intervention had no 
statistically significant effects on the primary 
outcomes, although one subgroup (those 
with an income of ≥C$50 000) significantly 
benefitted in terms of the mental health 
outcome. Qualitative and fidelity findings 
revealed aspects of the intervention that 
could be improved.
Strengths and limitations 
One strength was that the intervention 
was developed by providers and pre-tested 
before the trial. Intervention failure was 
not a problem here as it has been with 
other interventions.19 Co-creation of the 
intervention, as in Mercer et al,15 or provider 
creation, as in the present study, appear to 
avoid implementation lapses.
A second strength was that the intervention 
includes an explicit patient-centred 
component, whereas most intervention 
studies to date, addressed the organisation 
of care.8,32
A third strength was the mixed-method 
design providing insights into how and 
for whom it works or fails to work; this is 
important given the neutral or mixed results 
revealed in recent systematic reviews8,10–12 
and six recent trials.13–18
Other strengths include susceptibility 
bias, which was avoided by using envelopes 
in random sequence, while detection 
and follow-up bias was avoided by using 
sealed and opaque envelopes, and having 
a different staff member administer patient 
questionnaires. 
One limitation was the fact that the sample 
size was relatively small in comparison with 
other recent trials (although the estimated 
sample size of 128 was met) and that the 
sample was unrepresentative of the general 
population in Ontario, Canada. 
A second limitation was the lack of cost 
analyses. Healthcare utilisation outcomes, 
with their associated cost implications, will 
be handled in separate analyses that are 
underway. 
Third, the qualitative study was not a full 
process evaluation. Therefore, future studies 
may want to include a process evaluation 
involving patients plus providers and decision 
makers. 
Fourth, lack of alignment of outcome 
measures with intervention goals and patient 
expectations may be a problem.
Fifth, fidelity variations in some 
components of the intervention may have 
compromised impact.
Comparison with existing literature
The current study advances on previous work 
by testing an intervention that should enhance 
everyday practice. This intervention should 
overcome the problem of implementation 
lapses found in other studies,19 because 
it was provider created, which goes even 
further than a co-created intervention.15 The 
lack of impact on outcomes for patients 
with an income of <C$50 000 contrasts with 
Mercer et al ’s15 multifaceted intervention, 
which was effective for patients who 
were considered to be socioeconomically 
deprived; they focused on self-management 
support, more face-to-face time with 
patients, and continuity of care — aspects 
of care that could enhance follow-up to the 
TIP programme. A systematic review8 found 
improvements in mental health outcomes, 
as did the present study.
Implications for research and practice
Three possible explanations are offered for 
the neutral results in the pragmatic trial, 
each of which has implications for practice 
and research: the usual care received by 
the control group; the outcome measures; 
and the intervention itself. Each will 
be considered in turn. The first possible 
explanation is that usual care received by the 
Figure 2. Intervention and control group in relation to 
mental health statusa by income subgroups. 
aMean values of mental health status in a significant 
three-way interaction between treatment by time by 
income in an analysis by mixed model for repeated 
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control group may have been beneficial. The 
authors noted that the majority of control 
group patients experienced usual care within 
an Ontario-wide enhanced primary care 
team model, with interdisciplinary providers 
and continuity of care. The implication for 
practice is that some patients may benefit 
from the features of usual care whereas 
others may benefit from the multi-provider 
case conference, and future research can 
assist family physicians in their selection of 
which care is beneficial for which patients.
With regard to outcome measures, the 
trial presented here found a positive impact 
on the mental health outcome for a subgroup 
of patients and the qualitative findings 
focused on patients’ functional goals, as 
well as patients feeling validated, liberated, 
optimistic, and hopeful. Future research 
could use existing measures or develop 
new measures of mental health, patients’ 
function, and patients feeling validated.
With regard to the intervention itself, 
the qualitative findings and the fidelity 
assessment point out two aspects of the 
intervention that could be strengthened 
to enhance patient outcomes. Having 
≥6 providers in the case conference was 
linked to negative outcomes, suggesting that 
the ideal/optimal team composition may 
need to be tailored to patient preferences — 
tailoring has been proposed by others.18 The 
number of nurse hours during the follow-
up period, and how these hours are used, 
may need rethinking; such a rethink could 
involve increasing the involvement of the 
FP and the multidisciplinary team in the 
follow-up to better support the patients. 
Both of these findings regarding the number 
of providers and nursing hours imply a level 
of complexity that led to patient frustration 
(qualitatively); solutions to that may be 
specifically coalescing the plan into written, 
actionable steps and more support to the 
patient in carrying out the plan.
Patients qualitatively experienced 
promising effects of the very 
recommendations that required an extra 
outlay of costs — that is, those not covered 
by Ontario, Canada’s universal healthcare 
system — such as physiotherapy and 
psychotherapy. As well, patients’ income 
was implicated in the trial. In Toronto, 36% 
of people have an income of ≥C$50 000 and 
64% <C$50 000.49 The ≥C$50 000 income 
group seemed to benefit from the intervention 
and those <C$50 000 seemed to benefit 
from usual care. The result, if replicated, 
could influence decisions in practice such as 
advocating to ease costs for a lower-income 
patient, and should encourage policies to 
cover such services.
In practice, the intervention could be 
improved by optimising team composition 
to align with individual patient preferences 
and reducing any frustrations for patients by 
having a clear care plan with actionable steps. 
For the subgroup of patients experiencing 
deprivation, additional supports such as 
identifying sources of financial assistance 
will be needed.
In research, the differences between 
income groups need to be replicated. Also 
piloted, provider-created interventions 
could be trialled to diminish the difficulties 
of implementation experienced by some 
researchers.19
The study findings support a suggestion 
that future research assessing interventions 
for multimorbidity include outcome 
measures on mental health, patients’ 
function, and patients feeling validated.
In policy, equity in patient-centred 
multimorbidity care may become an 
increasingly compelling issue.
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